News
Shilpa Medicare has received approval from USFDA for Varenicline Tablets, 0.5 and 1 mg. The total US market for this product is around 203 M USD. Shilpa's product has been approved as a generic ...
14d
MedPage Today on MSNPrenatal Smoking Cessation Medication Did Not Increase Congenital MalformationsPrenatal use of smoking cessation therapies was not linked to increased risks of major congenital malformations (MCMs) compared with smoking during the first trimester, a retrospective cohort study ...
The nicotinic acetylcholine receptors (nAChRs) are the most well understood membrane receptors for neurotransmitters at the structural and functional level. They are integral allosteric membrane ...
Several studies have been done on the myriad list of side effects that come from popular weight loss drugs. A new study conducted by researchers from t… ...
Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.
Karnataka: Shilpa Medicare Limited has received approval from the US Food and Drugs Administration (USFDA) for Varenicline ...
The United States and New Zealand are the only countries that allow this type of advertising. None of this was legal until 1997 when the FDA authorized it. Perhaps it is not surprising that the FDA ...
Here's a comprehensive analysis of the provided text, extracting the requested company information with the greatest possible detail: 1. **Mission Statement or Core Values:** * The text explicitly ...
DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 176,000 newsletter subscribers for 21 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results